Categories: AppBioTechComputerDevelopmentITTechnology
PreciThera is a biotechnology company that develops therapies for rare bone diseases. It has developed a strategy that uses the combined application of computer technologies and in-depth understanding of each pathology.
Investors 2
Funding Rounds 1
Mentions in press and media 3
| Date | Title | Description |
| 28.07.2017 | Term Sheet — Friday, July 28 | CRYPTO WEEK CONTINUES
Happy Friday. It’s Jen Wieczner again, so keep the tips and feedback coming to jen.wieczner@fortune.com or on Twitter @jenwieczner. Erin is still on vacation, which means I can still fill your Term Sheet with, in her w... |
| 27.07.2017 | Arix Bioscience co-leads $29 million Series A financing for PreciThera, Inc. | - |
| 27.07.2017 | PreciThera Closes US$29M Series A Financing | PreciThera, Inc., a Montreal, Canada-based precision medicine company, dedicated to the design and development of innovative biological therapeutics for the treatment of orphan bone diseases, completed a CAD$36m (US$29m) Series A financing.... |
Reviews 0